Kiniksa Pharmaceuticals, Ltd.KNSANASDAQ
Loading
Net income as a percentage of revenue
3Y CAGR
-52.9%/yr
Annual compound
Percentile
P83
Within normal range
vs 3Y Ago
0.1x
Contraction
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | 8.71% | +185.3% |
| 2024 | -10.21% | -295.8% |
| 2023 | 5.21% | -93.7% |
| 2022 | 83.28% | +120.3% |
| 2021 | -409.72% | - |
| 2020 | 0.00% | - |
| 2019 | 0.00% | - |